Riccardo Cazzoli
UNSW Sydney(AU)European Institute of Oncology(IT)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Nanoparticle-Based Drug Delivery, Cancer-related molecular mechanisms research, Cancer-related Molecular Pathways, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer(2013)448 cited
- → Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis(2019)306 cited
- → RADICL-seq identifies general and cell type–specific principles of genome-wide RNA-chromatin interactions(2020)163 cited
- → Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer(2023)24 cited
- → RADICL-seq identifies general and cell type-specific principles of genome-wide RNA-chromatin interactions(2019)23 cited
- → Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition(2023)15 cited
- → Evolving approaches in glioma treatment: harnessing the potential of copper metabolism modulation(2023)8 cited
- → Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells(2024)8 cited
- → Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma(2024)7 cited
- → Cabozantinib in neuroendocrine tumors: tackling drug activity and resistance mechanisms(2023)5 cited